Marsh reported third quarter 2026 results on October 15, 2026. Revenue rose 8% to $6.9 billion, or 5% on an underlying basis, and GAAP diluted EPS was $1.69 versus $1.51 a year earlier. Adjusted EPS rose 10% to $2.03, while nine-month GAAP diluted EPS fell to $6.68 from $6.75.
Q3 2026 revenue was $6.9 billion, up 8% from $6.4 billion, or 5% on an underlying basis.
Q3 GAAP diluted EPS was $1.69 versus $1.51; adjusted EPS rose 10% to $2.03.
Nine-month GAAP diluted EPS was $6.68 versus $6.75; nine-month adjusted EPS rose 9% to $8.29.
In Q3 the company repurchased 2.7 million shares for $500 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Marsh McLennan's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$26.98B
+10.3%
$8.43
+3.1%
15.4%
FY2024
$24.46B
+7.6%
$8.18
+8.6%
16.6%
FY2023
$22.74B
+9.7%
$7.53
+24.7%
16.5%
FY2022
$20.72B
+4.5%
$6.04
-1.5%
14.7%
FY2021
$19.82B
+15.1%
$6.13
+55.6%
15.9%
Frequently asked questions
When is Marsh McLennan's next earnings date?
Marsh McLennan has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Marsh McLennan earn last quarter?
For the quarter ended Sep 2026, Marsh McLennan reported diluted EPS of $1.69 (+11.9% year over year) on revenue of $6.86B (+8.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.